Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Conditions
Interventions
None listed
Sponsors
Pierre Fabre Medicament
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Countries
France, Germany, Netherlands, Spain
Outcome results
None listed